Incyte brought in Richard Hoffman as their top lawyer to replace Sheila Denton, who's bouncing after the holidays. Hoffman was grinding at Goodwin as a partner handling biotech stuff out of Boston, and he'll be running legal and compliance while sitting on the executive squad at the Delaware pharma company that focuses on cancer and inflammation drugs.
The guy has been doing this for over 30 years with expertise in venture money, mergers, IPOs, and international partnerships. He spent almost 10 years at Goodwin after previous stints at WilmerHale and even started his own consulting gig helping early-stage biotech companies. Before law, he co-founded a couple of pharma businesses and worked in various non-legal roles in the industry.
Denton is heading out after a little over two years to chase other opportunities, though she stuck around through the transition period to help Hoffman get settled.
The guy has been doing this for over 30 years with expertise in venture money, mergers, IPOs, and international partnerships. He spent almost 10 years at Goodwin after previous stints at WilmerHale and even started his own consulting gig helping early-stage biotech companies. Before law, he co-founded a couple of pharma businesses and worked in various non-legal roles in the industry.
Denton is heading out after a little over two years to chase other opportunities, though she stuck around through the transition period to help Hoffman get settled.
